A $4.6 million grant from the Massachusetts Life Sciences Center (MLSC) will increase Dana-Farber’s capacity for manufacturing a wide variety of engineered cellular products for patients with cancer and other diseases, establish relationships with commercial partners to refine cell manufacturing processes, and provide manufactured products for patients enrolled in clinical trials.
Click here to read the article.